Teriflunomide Observational Effectiveness Study

NCT02490982 · clinicaltrials.gov ↗

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: Teriflunomide

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

[object Object]
[object Object]